Trial Profile
Postmarketing surveillance study of tocilizumab in Japanese patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 13 Jun 2015 Results of 3-year extension study in 5573 patients presented at the 16th Annual Congress of the European League Against Rheumatism.
- 11 Nov 2011 New trial record
- 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.